These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 17628012)
1. The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. Spivak CE; Lupica CR; Oz M Mol Pharmacol; 2007 Oct; 72(4):1024-32. PubMed ID: 17628012 [TBL] [Abstract][Full Text] [Related]
2. Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. Butt C; Alptekin A; Shippenberg T; Oz M J Neurochem; 2008 May; 105(4):1235-43. PubMed ID: 18194436 [TBL] [Abstract][Full Text] [Related]
3. The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. Oz M; Ravindran A; Diaz-Ruiz O; Zhang L; Morales M J Pharmacol Exp Ther; 2003 Sep; 306(3):1003-10. PubMed ID: 12766252 [TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. Oz M; Yang KH; Dinc M; Shippenberg TS J Pharmacol Exp Ther; 2007 Nov; 323(2):547-54. PubMed ID: 17682128 [TBL] [Abstract][Full Text] [Related]
5. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes. Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666 [TBL] [Abstract][Full Text] [Related]
6. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Pratt PF; Hillard CJ; Edgemond WS; Campbell WB Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889 [TBL] [Abstract][Full Text] [Related]
7. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts]. Liao YS; Wu J; Wang P; Zhang H Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494 [TBL] [Abstract][Full Text] [Related]
8. Additive effects of endogenous cannabinoid anandamide and ethanol on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. Oz M; Jackson SN; Woods AS; Morales M; Zhang L J Pharmacol Exp Ther; 2005 Jun; 313(3):1272-80. PubMed ID: 15687372 [TBL] [Abstract][Full Text] [Related]
9. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. White R; Hiley CR Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of desensitization and recovery from desensitization for human alpha4beta2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells. Yu KD; Liu Q; Wu J; Lukas RJ Acta Pharmacol Sin; 2009 Jun; 30(6):805-17. PubMed ID: 19498421 [TBL] [Abstract][Full Text] [Related]
11. Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid. Ronco AM; Llanos M; Tamayo D; Hirsch S Pharmacology; 2007; 79(1):12-6. PubMed ID: 17114903 [TBL] [Abstract][Full Text] [Related]
12. Effects of endogenous cannabinoid anandamide on cardiac Na⁺/Ca²⁺ exchanger. Al Kury LT; Yang KH; Thayyullathil FT; Rajesh M; Ali RM; Shuba YM; Howarth FC; Galadari S; Oz M Cell Calcium; 2014 May; 55(5):231-7. PubMed ID: 24674601 [TBL] [Abstract][Full Text] [Related]
13. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515 [TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Scorticati C; Fernández-Solari J; De Laurentiis A; Mohn C; Prestifilippo JP; Lasaga M; Seilicovich A; Billi S; Franchi A; McCann SM; Rettori V Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11891-6. PubMed ID: 15280536 [TBL] [Abstract][Full Text] [Related]
15. Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. Jackson SN; Singhal SK; Woods AS; Morales M; Shippenberg T; Zhang L; Oz M Eur J Pharmacol; 2008 Mar; 582(1-3):42-51. PubMed ID: 18242598 [TBL] [Abstract][Full Text] [Related]
16. Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. Xiong W; Hosoi M; Koo BN; Zhang L Mol Pharmacol; 2008 Feb; 73(2):314-22. PubMed ID: 17993512 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis. Pasquariello N; Catanzaro G; Marzano V; Amadio D; Barcaroli D; Oddi S; Federici G; Urbani A; Finazzi Agrò A; Maccarrone M J Biol Chem; 2009 Oct; 284(43):29413-26. PubMed ID: 19690173 [TBL] [Abstract][Full Text] [Related]
18. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors. Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895 [TBL] [Abstract][Full Text] [Related]
19. U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line. Zheng C; Wang MY; Liu Q; Wakui M; Whiteaker P; Lukas RJ; Wu J J Neurochem; 2009 Mar; 108(6):1526-38. PubMed ID: 19183258 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Calignano A; La Rana G; Makriyannis A; Lin SY; Beltramo M; Piomelli D Eur J Pharmacol; 1997 Dec; 340(2-3):R7-8. PubMed ID: 9537804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]